VitalConnect Announces Investment from HCA Healthcare to Accelerate Commercial Growth and Create Strategic Partnership

Rhea-AI Summary

VitalConnect, a leader in wearable biosensor technology, announced a strategic investment from HCA Healthcare to accelerate its cardiac monitoring business. This funding will enhance the company's efforts in Remote Patient Monitoring for conditions such as heart failure, COPD, and sepsis. The investment aims to support ongoing growth and technology advancements in patient monitoring, which has seen significant adoption by healthcare providers.

Positive

• Investment from HCA Healthcare to accelerate growth in cardiac monitoring.
• Increased focus on Remote Patient Monitoring for chronic conditions.
• Significant physician adoption of VitalConnect's technology in the last 18 months.

Negative

• None.

Strategic Investment Expected to Help Accelerate Cardiac Monitoring and Strategic Relationship Aims to Create Improved Disease State Treatment Models

SAN JOSE, Calif.--(BUSINESS WIRE)-- VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, today announced the completion of an investment funded by Health Insight Capital, the investment arm of HCA Healthcare Inc., (NYSE: HCA), one of the nation’s leading healthcare providers. The investment will go toward further accelerating VitalConnect’s rapidly growing cardiac monitoring business segment while advancing key Remote Patient Monitoring of individuals who have experienced heart failure (HF), chronic obstructive pulmonary disease (COPD) and sepsis, among others. This funding support is expected to help VitalConnect continue bringing the most advanced technology to patients and providers.

“This strategic investment from HCA Healthcare will further accelerate VitalConnect’s expansive growth and upward trajectory in the Cardiac Monitoring space,” said Peter Van Haur, CEO, VitalConnect. “We’ve experienced unparalleled physician adoption and growth over the past 18 months since launch, and HCA Healthcare’s investment will enable us to continue bringing customers the most comprehensive remote patient monitoring platform.”

Founded in 2011, VitalConnect has deployed hundreds of thousands of biosensors throughout the world, including care facilities such as Brigham and Women’s, Hackensack Medical Center, Northwell Health, and John Radcliffe Hospital-Oxford University. The VitalPatch allows real-time remote or in-hospital monitoring, allowing physicians to optimize the delivery of care to their patients.

About VitalConnect, Inc.

VitalConnect is a leader in wearable biosensor technology for wireless patient monitoring in both hospital and remote patient populations. VitalConnect leverages extensive expertise in biomedical engineering, data analytics, chip design, and mobile and cloud software to create technology that supports decision-making paradigms that achieve better health and economic outcomes. VitalConnect’s products are designed for use in a broad range of inpatient and outpatient settings, such as hospital monitoring, post-discharge care, cardiac monitoring and pharmaceutical solutions. VitalConnect’s advanced yet easy-to-use platform, was designed to deliver better healthcare at lower costs while providing more convenience for the patients and healthcare providers. For more information: www.vitalconnect.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220912005202/en/

Steve Kelly

VitalConnect, Inc.

206-856-6488

skelly@vitalconnect.com

Source: VitalConnect, Inc.

FAQ

What is the recent investment made by HCA Healthcare?

HCA Healthcare has made a strategic investment in VitalConnect to accelerate its cardiac monitoring business.

How will the investment from HCA affect VitalConnect?

The investment will enhance VitalConnect's capabilities in Remote Patient Monitoring and support its growth in cardiac monitoring.

What conditions are being targeted by VitalConnect's technology?

VitalConnect's technology focuses on monitoring heart failure, COPD, and sepsis among others.

What has been the adoption rate of VitalConnect's technology?

VitalConnect has experienced significant physician adoption and growth in the past 18 months.